Protocol I4V-MC-JADW: Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib (LY3009104) in Pat

Printer-friendly versionPDF version

Name

Lilly USA, LLC

Anticipated Amount

85 185.00

Activity Type

Clinical Trial

Award Type

Contract

Date

October 1, 2012 to May 30, 2015

Award Number

006021-00001

Sponsor Award Number

14V-MC-JADW

Award Contacts

Name

Lisse,Jeffrey R

Title

Principal Investigator

Unit

Arthritis Center-Research

UA@Work is produced by University Communications

Marshall Building, Suite 100. 845 N. Park Ave., Tucson, AZ 85719 (or) 
P.O. Box 210158B, Tucson, AZ 85721

T 520.621.1877  F 520.626.4121

Feedback University Privacy Statement 

2024 © The Arizona Board of Regents on behalf of the University of Arizona